Skip to Main Content

Paper Details

Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study.
Neuro Oncol
2
2022
450K DNA, AR, DF, G3, MB, Medulloblastoma, PSF, SHH, SHH tumors, WNT, autologous stem, clinical target volume, medulloblastoma, patients, pediatric, primary site
Author NameAffiliation
Giles W RobinsonSt. Jude Children's Research Hospital
Giles W RobinsonSt. Jude Children's Research Hospital
Brent A OrrSt. Jude Children's Research Hospital
Paul A NorthcottSt. Jude Children's Research Hospital
Paul A NorthcottSt. Jude Children's Research Hospital
David W EllisonSt. Jude Children's Research Hospital
Amar GajjarSt. Jude Children's Research Hospital
  • 1 - 7

Datasets

Release 1.2